The report provides a detailed analysis essential for establishing a Cloxacillin production plant. It encompasses all critical aspects necessary for Cloxacillin production, including the cost of Cloxacillin production, Cloxacillin plant cost, Cloxacillin production costs, and the overall Cloxacillin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cloxacillin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cloxacillin is a semi-synthetic penicillin antibiotic that is mainly used in the pharmaceutical and healthcare sectors. It is primarily prescribed for the treatment of bacterial infections caused by penicillin-resistant Staphylococcus species. It is widely used in the treatment of skin and soft tissue infections, bone and joint infections, and urinary tract infections.
It is also used in managing respiratory tract infections, wound infections, and post-surgical infections. It is commonly formulated as oral capsules, syrups, and injectable preparations for hospital use, which makes it suitable for both oral and parenteral administration. It is also used to treat mastitis in dairy cattle and other bacterial infections in animals. In addition, cloxacillin is also widely used in clinical practice and antibiotic research to study resistance patterns and to develop effective treatment options against resistant bacterial strains.
The primary factor that drives the market for Cloxacillin is its demand as an antibiotic drug in the treatment of infections caused by penicillinase-producing staphylococci, which are resistant to regular penicillin. Its application as a broad-spectrum antibacterial drug for the treatment of bacterial infections affecting the skin, soft tissues, bones, and joints significantly boosts its demand in the pharmaceutical industry. Its demand in the treatment of infections caused by beta-lactamase-producing staphylococci largely drives its market growth.
Its usage in veterinary medicine, especially for treating mastitis in dairy cattle, further supports its demand across the healthcare and animal health sectors. In addition, rising antibiotic resistance and the growing need for effective narrow-spectrum antibiotics also drive its demand in clinical practice. Moreover, supplier consistency, formulation technology improvements, and supply chain efficiency also play important roles in shaping the global market for Cloxacillin. Industrial Cloxacillin procurement is influenced by factors such as the availability and cost of raw materials like 6-APA and side chain intermediates, stringent quality standards, regulatory approvals, and adherence to good production practices.
Raw Material for Cloxacillin Production
According to the Cloxacillin production plant project report, the major raw materials for Cloxacillin production include 6-Aminopenicillanic Acid (6-APA) and 3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxylic Acid.
Production Process of Cloxacillin
The extensive Cloxacillin production cost report consists of the following industrial production process:
- Production via Chemical Synthesis: The production process of Cloxacillin begins with the acylation of 6-aminopenicillanic acid (6-APA) using 3-(o-chlorophenyl)-5-methyl-4-isoxazolecarboxylic acid. In this process, the acyl group attaches to the amino group of 6-APA to form cloxacillin acid. Then, the intermediate is subjected to purification through repeated recrystallisations to remove impurities and ensure product quality. After achieving the desired purity, the cloxacillin acid is converted into its sodium salt form by reacting it with a suitable sodium compound in an aqueous or alcoholic medium. The complete reaction results in the formation of sodium cloxacillin as the final product.
Cloxacillin is a semisynthetic beta-lactamase-resistant penicillin antibiotic that belongs to the isoxazolylpenicillin group. It appears as a white to pale yellow or off-white crystalline powder that is solid at room temperature and is odourless. The molecular formula of the compound is C19H18ClN3O5S, and its molecular mass is 435.88 g/mol. The compound is commonly used in its sodium salt monohydrate form, which has a molecular formula of C19H17ClN3NaO5S·H2O and a molecular mass of 475.88 g/mol. It is completely soluble in alcohol but only slightly soluble in acetone and chloroform. The boiling point of the compound is 689.7 degree Celsius. It is particularly effective against gram-positive bacteria such as Staphylococcus aureus and Streptococcus pneumoniae, but not against methicillin-resistant strains. The aqueous solutions of the compound for injections are stable for at least 3 days, if refrigerated. Common side effects include nausea, diarrhoea, gastrointestinal upset, and allergic reactions, including anaphylaxis in susceptible individuals. It is contraindicated in patients with known hypersensitivity to penicillins, and caution is advised regarding potential cross-reactivity with other beta-lactam antibiotics.
